论文部分内容阅读
“非典”期间,原本平淡的国内生物技术(BT)产业一下子变得活跃了起来,但那些尚处在摸索阶段的国内BT企业们,能否在短期内真正开启自己的远大“钱”程?
During the SARS period, the originally bland domestic biotechnology (BT) industry suddenly became active. However, those domestic BT enterprises that are still at a groping stage can truly open their own “big money” programs in the short term ?